# BEO Pharma Inc – FDA Inspection, Nov 4, 2024

Source: https://www.keypedia.com/records/fda_inspections/beo-pharma-inc/e258df89-955c-4c64-bc54-2dbe54610e44
Source feed: FDA_Inspections

> FDA inspection 1253295 of BEO Pharma Inc, November 04, 2024. Classification: Official Action Indicated (OAI). 5 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1253295
- Company Name: BEO Pharma Inc
- Inspection Date: 2024-11-04
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Florida District Office
- Citation Count: 5

## Related Documents

- [FDA Inspection 1337028 - 2026-09-18](https://www.keypedia.com/records/fda_inspections/beo-pharma-inc/19e1311a-bde9-484c-9ebd-ff49e147a1b0)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kayla-v-sprague/154cb543-111b-4ad1-b45b-43900df71b90)

Company: https://www.keypedia.com/companies/beo-pharma-inc/bc2943c1-de0c-4bf5-b29b-49563229a8fb

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9
